Gene linked to type 1 diabetes

July 01, 2002

A newly discovered gene plays a dramatic role in diabetes among rats, and is also present in nearly identical form in humans, according to researchers at the University of Washington and their colleagues. Further study of the gene may shed light on little-understood processes of the thymus, a vital part of the body's immune system, which sometimes attacks insulin-producing cells in the pancreas leading to type 1 diabetes.

"This gene appears to be absolutely necessary for the development of diabetes in the BB rat, the best model for human type 1 diabetes," says Dr. Åke Lernmark, R. H. Williams Professor of Medicine and adjunct professor of immunology at the University of Washington in Seattle. "The identification of this gene will help us figure out how a gene can fully control if the rat will get diabetes or not. We think this gene may also contribute to human type 1 diabetes."

Lernmark is senior author of a paper describing the findings, published in the July issue of Genome Research. The research was supported by the National Institute of Allergy and Infectious Disease, one of the National Institutes of Health. The work is a collaboration in rat genomics with, among others, Drs. Howard Jacob and Anne Kwitek at the Medical College of Wisconsin in Milwaukee and Dr. Eric Lander at the Whitehead Institute in Cambridge, Mass. Jacob is the Warren P. Knowles Professor of Human and Molecular Genetics and Physiology and director of the genetics center. Kwitek is assistant professor of physiology. Lander is director of the Whitehead's Center for Genome Research.

Type 1 diabetes affects between 0.3 and 1 percent of humans, depending on what population is being surveyed. For more than 20 years, researchers have been studying a particular breed of rat, known as the BB rat, which naturally develops type 1 diabetes and dies unless given insulin. In the current work, the researchers have succeeded in using positional cloning to identify a novel gene, dubbed Ian5 (pronounced 'I A N 5"), with a mutation that results in the deletion of a protein that is found in, among other places, the thymus.

To understand why that's important, it's important to understand the type 1 disease process. Inside the bodies of both humans and rats, bone marrow produces white blood cells, such as T cells, that leave the marrow and travel to the thymus for filtering and processing. The thymus filters and rejects T cells that would harm the body. In a process that is less understood, a healthy thymus then incubates T cells that will be released into the body to fight infections.

In type 1 diabetes, something goes wrong. T cells are released from the thymus 'thinking' that insulin-producing cells in the pancreas represent an infection that needs to be destroyed. In fact, the insulin-producing cells in the pancreas are necessary to life. When the T cells attack and destroy those insulin-producing cells in the pancreas, the body has to get insulin from another source. This condition is type 1 diabetes, and human patients as well as BB rats will have to take daily shots of insulin to survive.

"Something in the immune system is going wrong. No one is sure exactly what. Now that we have identified the specific gene that is causing an immune system defect, we can try to understand how that gene is acting in its particular context in the immune system normally," said Dr. Armand J. MacMurray, first author of the paper and a senior fellow in the University of Washington's Division of Metabolism, Endocrinology and Nutrition. "That will help us understand what is happening abnormally that is predisposing the rats to the disease, and then see what we can learn about any similar process within humans."

Besides studying the exact function of the Ian5 gene and its protein, researchers will survey if there are any people with type 1 diabetes who may have variants of the Ian5 gene. They have determined that people have an Ian5 gene in the location on chromosome 7 that corresponds to the rat gene's position on its chromosome 4.

This is not the only animal model for diabetes. Other researchers have been scrutinizing the NOD mouse, which also tends to develop type 1 diabetes, but most of its genetic markers don't appear to be as easily isolated. Several authors of the current paper identified in 1992 that there must be a gene on rat chromosome 4 that causes diabetes; they identified the particular gene, Ian5, on the chromosome in January.

Researchers hope that a better understanding of the gene and the function of the thymus could help find answers for diabetes. "One hypothesis is that Ian5, in its regular form, allows T cells to mature properly in the thymus. But perhaps because of this gross defect in the gene, the thymus allows the creation of the defective T cells that are at the root of diabetes," MacMurray says.

Lernmark and colleagues identified a genotype, HLA DQ2/8, which may be responsible for 60 percent of the genetic contribution to type 1 diabetes. Researchers know that it's only responsible for some type 1 diabetes. For example, about 3 percent of children in the state of Washington have the genotype HLA DQ2/8. But of them, only one in 30 of them will develop type 1 diabetes before age 15. So something else besides HLA DQ2/8 must be influencing the outcome. Lernmark speculates that the newly sequenced Ian5 may be a contributing factor to the other 40 percent of genetic contributions.

"Now that Ian5 has been identified also in humans, the team is optimistic that it should not take another 10 years to find out if Ian5 contributes to human type 1 diabetes," Lernmark says.
-end-


University of Washington

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.